Wearable sensor could unmask hidden blood sugar chaos in stomach paralysis

NCT ID NCT06046833

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This pilot study is testing whether a real-time continuous glucose monitor (FreeStyle Libre 3) can reveal differences in blood sugar patterns between people with diabetes who have gastroparesis (delayed stomach emptying) and those without it. About 50 adults with type 1 or type 2 diabetes will wear the sensor, which measures glucose every minute, and drink a nutritional shake to see how their blood sugar responds. The goal is to understand how gastroparesis affects glucose control, which could lead to better management strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
FreeStyle Libre 3 continuous glucose monitoring sensor and a nutritional drink (Boost Plus)
What this could lead to
If successful, this could improve how blood sugar is managed in people with diabetes and gastroparesis, potentially reducing dangerous glucose swings.
What could go wrong
This is a small pilot study, so results may not apply to everyone. The sensor and drink may not fully capture real-world conditions, and no treatment is being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cleveland Clinic Foundation

    RECRUITING

    Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.